SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cell Host & Microbe

Topics

Biology

Immunology

Economics

Medicine

Pathology

Show all topics

DOI

10.1016/j.chom.2021.03.002

License

publisher-specific-oa